Literature DB >> 24163791

Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy.

David P Kao, Eileen Hsich, JoAnn Lindenfeld.   

Abstract

OBJECTIVES: The aim of this study was to identify clinical features associated with peripartum cardiomyopathy (PPCM) and possible racial differences and to quantify in-hospital outcomes in delivering mothers with PPCM.
BACKGROUND: Investigation of patient characteristics and outcomes in PPCM has been limited to small cohorts. Hospital discharge data allow assembly of the largest number of PPCM cases to date.
METHODS: Hospital records from 6 states were screened for PPCM. Clinical profiles, maternal, and fetal outcomes in delivering mothers with and without PPCM were compared and stratified by race. A maternal major adverse event (MAE) was defined as death, cardiac arrest, heart transplantation, or mechanical circulatory support. Logistic regression was used to identify variables associated with PPCM.
RESULTS: In total, 535 of 4,003,914 records of delivering mothers specified a diagnosis of PPCM. Prevalence of PPCM was highest among African Americans and similar in Caucasians and Hispanics. Established risk factors including age 30 years, African- American race, hypertension, preeclampsia/eclampsia, and multigestational status were associated with PPCM, and novel associations such as anemia and asthma were identified. Autoimmune disease and substance abuse, which can cause cardiomyopathy independently, were also associated with PPCM. Maternal MAE (odds ratio: 436, p < 0.0001) and stillbirth (odds ratio: 3.8, p < 0.0001) occurred more frequently among women with PPCM.
CONCLUSIONS: The prevalence of PPCM at the time of delivery in Hispanics was similar to Caucasians and lower than African Americans. Autoimmune disease, substance abuse, anemia and asthma were conditions associated with PPCM not consistently identified in smaller cohorts. Peripartum cardiomyopathy was also associated with increased risk of stillbirth and maternal MAEs at delivery.

Entities:  

Mesh:

Year:  2013        PMID: 24163791      PMCID: PMC3806506          DOI: 10.1016/j.jchf.2013.04.011

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  21 in total

1.  Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.

Authors:  U Elkayam; P P Tummala; K Rao; M W Akhter; I S Karaalp; O R Wani; A Hameed; I Gviazda; A Shotan
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

Review 2.  Peripartum cardiomyopathy: a comprehensive review.

Authors:  John Abboud; Yahya Murad; Carol Chen-Scarabelli; Louis Saravolatz; Tiziano M Scarabelli
Journal:  Int J Cardiol       Date:  2007-01-17       Impact factor: 4.164

3.  Incidence, mortality, and racial differences in peripartum cardiomyopathy.

Authors:  Somjot S Brar; Steven S Khan; Gagandeep K Sandhu; Michael B Jorgensen; Neil Parikh; Jin-Wen Y Hsu; Albert Yuh-Jer Shen
Journal:  Am J Cardiol       Date:  2007-06-06       Impact factor: 2.778

Review 4.  Inflammatory dilated cardiomyopathy (DCMI).

Authors:  Bernhard Maisch; Anette Richter; Andrea Sandmöller; Irene Portig; Sabine Pankuweit
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

Review 5.  Epidemiology and etiology of cardiomyopathy in Africa.

Authors:  Karen Sliwa; Albertino Damasceno; Bongani M Mayosi
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

6.  Frequency of peripartum cardiomyopathy.

Authors:  Lisa M Mielniczuk; Kathryn Williams; Darryl R Davis; Anthony S L Tang; Robert Lemery; Martin S Green; Michael H Gollob; Haissam Haddad; David H Birnie
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

7.  Improved outcomes in peripartum cardiomyopathy with contemporary.

Authors:  Ankie M Amos; Wissam A Jaber; Stuart D Russell
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

Review 8.  Peripartum cardiomyopathy.

Authors:  Karen Sliwa; James Fett; Uri Elkayam
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

9.  Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

Authors:  Karen Sliwa; Lori Blauwet; Kemi Tibazarwa; Elena Libhaber; Jan-Peter Smedema; Anthony Becker; John McMurray; Hatice Yamac; Saida Labidi; Ingrid Struman; Ingrid Struhman; Denise Hilfiker-Kleiner
Journal:  Circulation       Date:  2010-03-22       Impact factor: 29.690

10.  Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  William T Abraham; Gregg C Fonarow; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

View more
  26 in total

1.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

2.  Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).

Authors:  Dennis M McNamara; Uri Elkayam; Rami Alharethi; Julie Damp; Eileen Hsich; Gregory Ewald; Kalgi Modi; Jeffrey D Alexis; Gautam V Ramani; Marc J Semigran; Jennifer Haythe; David W Markham; Josef Marek; John Gorcsan; Wen-Chi Wu; Yan Lin; Indrani Halder; Jessica Pisarcik; Leslie T Cooper; James D Fett
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

3.  Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy.

Authors:  Masataka Sugahara; Nobuyuki Kagiyama; Nina E Hasselberg; Lori A Blauwet; Joan Briller; Leslie Cooper; James D Fett; Eileen Hsich; Gretchen Wells; Dennis McNamara; John Gorcsan
Journal:  J Am Soc Echocardiogr       Date:  2019-09-25       Impact factor: 5.251

Review 4.  Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.

Authors:  Natalie A Bello; Zoltan Arany
Journal:  Trends Cardiovasc Med       Date:  2015-01-15       Impact factor: 6.677

5.  In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2017-02-23       Impact factor: 2.037

6.  Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.

Authors:  Julie Damp; Michael M Givertz; Marc Semigran; Rami Alharethi; Gregory Ewald; G Michael Felker; Biykem Bozkurt; John Boehmer; Jennifer Haythe; Hal Skopicki; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; John Gorcsan; Sarosh Rana; Zoltan Arany; James D Fett; Dennis M McNamara
Journal:  JACC Heart Fail       Date:  2016-03-09       Impact factor: 12.035

7.  Development of an experimental model of maternal allergic asthma during pregnancy.

Authors:  Vicki L Clifton; Timothy J M Moss; Amy L Wooldridge; Kathryn L Gatford; Bahar Liravi; Dasom Kim; Beverly S Muhlhausler; Janna L Morrison; Andrew Davies; Robert De Matteo; Megan J Wallace; Robert J Bischof
Journal:  J Physiol       Date:  2015-09-02       Impact factor: 5.182

Review 8.  Peripartum cardiomyopathy: A puzzle closer to solution.

Authors:  James D Fett
Journal:  World J Cardiol       Date:  2014-03-26

9.  Cardiac Remodeling During Pregnancy With Metabolic Syndrome: Prologue of Pathological Remodeling.

Authors:  Yijun Yang; Justin Kurian; Giana Schena; Jaslyn Johnson; Hajime Kubo; Joshua G Travers; Chunya Kang; Anna Maria Lucchese; Deborah M Eaton; Maoting Lv; Na Li; Lorianna G Leynes; Daohai Yu; Fengzhen Yang; Timothy A McKinsey; Raj Kishore; Mohsin Khan; Sadia Mohsin; Steven R Houser
Journal:  Circulation       Date:  2021-02-15       Impact factor: 29.690

Review 10.  Peripartum cardiomyopathy.

Authors:  Nivedita Jha; Ajay Kumar Jha
Journal:  Heart Fail Rev       Date:  2021-01-13       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.